Form D · Other Health Care
Amani Therapeutics, Inc.
New York, NY · CIK 0002099941
Offering snapshot reported Oct 1, 2026 · SEC filing
- Reported sold
- $35M Offering amount: $60M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 16, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2026 | Initial | $34,999,999 | No comparison | 5 | SEC filing |
| Dec 10, 2025 | Initial | $31,120,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-599589
Source: Form D, filed Oct 1, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lauren Cuje | Director |
| Peter Fong | Director |
| Alice Lee | Executive |
| Rtw Holdings Vi, Llc | Promoter |
| Robert Swoboda | Executive |
| Connor Williams | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
40 10 Th Avenue Floor 7
New York, NY, 10014
New York, NY, 10014